Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

284 ARTÍCULOS , VIENDO DEL 196 AL 210

Safety and Efficacy of the AMPA Receptor Antagonist Perampanel for Tremors: A Systematic Review

Manalo RVM, Dela Cruz JRC, Pasco PM.

Acta Med Philipp. 2025 Sep 15;59(13):74-81. doi: 10.47895/amp.vi0.11650. eCollection 2025.

Movement disorders associated with acetylcholinesterase inhibitors in Alzheimer's dementia: A systematic review

Rissardo JP, Caprara ALF.

Brain Circ. 2025 Mar 21;11(1):9-23. doi: 10.4103/bc.bc_134_24. eCollection 2025 Jan-Mar.

Involuntary movements in patients with impaired awareness: A comparative study of phenomenology and neurophysiological evaluation

Coelho P, Kauppila LA, Franco AC, Bentes C, Valadas A, Coelho M, Peralta AR.

Seizure. 2025 Nov;132:82-87. doi: 10.1016/j.seizure.2025.08.004. Epub 2025 Aug 7.

Long-Term Efficacy of Bilateral Globus Pallidus Internus Deep Brain Stimulation in Myoclonus-Dystonia Associated with KCNN2 Gene Mutation: A Case Study

Stodulska O, Milanowski L, Koziorowski D, Mandat T, Szlufik S.

Int J Mol Sci. 2025 Aug 10;26(16):7736. doi: 10.3390/ijms26167736.

Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystonia

Pauly MG, Thomsen M, Tadic V, Busch H, Depienne C, Lohmann K, Klein C, Brüggemann N.

Parkinsonism Relat Disord. 2025 Feb;131:107260. doi: 10.1016/j.parkreldis.2025.107260. Epub 2025 Jan 2.

Myoclonus-Dystonia plus Syndrome in a Patient Carrying a Novel TCF20 Variant

Magistrelli L, Contaldi E, D'Alfonso S, Corrado L.

Mov Disord Clin Pract. 2025 Jan;12(1):105-107. doi: 10.1002/mdc3.14241. Epub 2024 Oct 25.

Sodium Oxybate-Treated Familial Myoclonus-Dystonia Syndrome Due to Novel SGCE Variant

Alghamdi MA, Hamad MH, Alghamdi I, Alghamdi G, Al-Jelaify M, Alshimemeri S, Hamed H, Adly N, Salih MA, Almontashiri NA, Bashiri FA.

Am J Med Genet A. 2025 May;197(5):e63964. doi: 10.1002/ajmg.a.63964. Epub 2024 Dec 20.

Expanding the Phenotypic Horizon of VAC14-Related Neurodegeneration

Chowdhury SR, Singh T, Meena R, Ganguly J, Sharma S.

Mov Disord Clin Pract. 2025 Oct;12(10):1664-1667. doi: 10.1002/mdc3.70127. Epub 2025 May 19.

Myoclonic status epilepticus with dystonia-like symptoms in patients with dementia: Report of two cases

Rossi RV, Melis R, Murdeu N, Lizzos S, Piras ML, Racis L, Serusi S, Saddi MV.

Epilepsy Behav Rep. 2025 Feb 4;29:100750. doi: 10.1016/j.ebr.2025.100750. eCollection 2025 Mar.

Infantile Epsilon-Sarcoglycan (SGCE) Myoclonus-Dystonia: Diagnostic Pitfalls and Poor Response to Pharmacologic Treatment

Pissarra R, Dias L, Sousa R, Melo C.

Cureus. 2025 Dec 29;17(12):e100342. doi: 10.7759/cureus.100342. eCollection 2025 Dec.

Utility and Value of Movement Recording with Combined EEG-EMG Monitoring in the Intensive Care Unit

Lévi-Strauss J, Marois C, Worbe Y, Bedoucha L, Benchikh Lehocine R, Rohaut B, Weiss N, Demeret S, Apartis E, Lambrecq V.

Neurocrit Care. 2025 Aug;43(1):333-344. doi: 10.1007/s12028-025-02230-3. Epub 2025 Mar 3.

DPPX antibody-mediated disease mimicking Wernicke's encephalopathy

Soliman Y, Irani N, O'Connor K.

BMJ Case Rep. 2025 Jan 2;18(1):e262573. doi: 10.1136/bcr-2024-262573.

SGCE Myoclonus Dystonia: A Case Report

Deginet E, Tewoflos M, Abebe YN.

Ethiop J Health Sci. 2025 May;35(3):222-224. doi: 10.4314/ejhs.v35i3.11.

Functional Movement Disorder: Evolving Mechanisms, Diagnostic Precision, and Personalized Multidisciplinary Care

Ortega-Robles E, Shalash A, Ramírez-Bermúdez J, Arias-Carrión O.

Mov Disord Clin Pract. 2025 Sep;12(9):1244-1258. doi: 10.1002/mdc3.70136. Epub 2025 May 19.

Efficacy and safety of multiple-target deep brain stimulation in non-parkinsonian movement disorders: a systematic review

Kalogirou E, Voulgaris S, Alexiou GA.

Neurosurg Rev. 2025 Jun 17;48(1):512. doi: 10.1007/s10143-025-03661-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias